Login / Signup

Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.

Shunsuke YokotaKoichi KameiShuichiro FujinagaRiku HamadaAya InabaKentaro NishiMai SatoMasao OguraKoji SakurayaShuichi Ito
Published in: Pediatric nephrology (Berlin, Germany) (2024)
Early administration of rituximab in combination with MPT and immunosuppressants might achieve favorable outcomes in patients with SRNS.
Keyphrases
  • poor prognosis
  • diffuse large b cell lymphoma
  • long non coding rna
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • type diabetes
  • childhood cancer
  • young adults